FDA Inspection 1251751 — AMHWA Biopharm Co., Ltd
The FDA completed an inspection of AMHWA Biopharm Co., Ltd on September 12, 2024 in Binzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Binzhou (China)